Cenovus Energy Inc.

CVE

CVE, or Common Vulnerabilities and Exposures, is not a stock but a standardized identifier system for publicly known cybersecurity vulnerabilities operated by MITRE Corporation.
It serves as a critical reference system enabling universal communication and tracking of security flaws across the tech industry.

$22.31 +0.24 (+1.09%)

Updated: February 27, 2026, 16:00 EST

Analyzed by Rockflow Bobby Quantitative Model āœ“ Updated Daily

Investment Opinion: Should I buy CVE Today?

Analysis of Cenovus Energy (CVE)

Technical Analysis CVE demonstrates impressive momentum with substantial outperformance against the market over recent months, accompanied by lower volatility as indicated by its low beta. While trading near its 52-week high suggests strength, investors should note potential resistance levels given the stock's maximum drawdown history.

Fundamentals Recent quarterly results reveal pressure on revenue and profitability, with significant declines from the previous quarter. However, the company maintains a stable financial position with moderate leverage and adequate liquidity, though operational efficiency metrics indicate room for improvement in capital utilization.

Valuation CVE's valuation appears reasonable based on trailing and forward P/E ratios, but the negative PEG ratio signals caution regarding future earnings growth. The lack of industry peer data limits the ability to fully assess its competitive valuation positioning.

Risk The stock exhibits lower systematic risk due to its low beta, yet its historical drawdown highlights potential for notable declines. General sector risks, such as commodity price exposure, persist despite the absence of significant short interest.

---

Recommendation

BUY – CVE presents a compelling case based on its strong price momentum and reasonable valuation multiples. While recent fundamentals show some weakness, the company's solid financial health and efficient working capital management provide a stable foundation. Investors should monitor quarterly performance for signs of improved operational efficiency and be mindful of sector-specific risks. This analysis is for informational purposes only and not investment advice.

CTA Banner

CVE 12-Month Price Forecast

RockFlow Model Forecast: Three Scenarios for 2026

Based on the provided analysis, here is a 12-month outlook for Cenovus Energy (CVE):

12-Month Outlook for Cenovus Energy (CVE)

The 12-month outlook for CVE is cautiously optimistic, hinging on a rebound in operational efficiency and stable commodity prices. The key catalyst will be translating its strong technical momentum and solid financial health into improved quarterly revenue and profitability. A primary risk remains the stock's sensitivity to volatile energy prices, which could trigger significant drawdowns despite its low beta, especially if operational metrics do not improve. Given the lack of a specific analyst target, a reasonable price range would be contingent on sector performance, but maintaining current levels near the 52-week high would suggest success, while failure to address fundamental weaknesses could see a retreat toward lower support levels.

Wall Street Consensus

Most Wall Street analysts are optimistic about Cenovus Energy Inc.'s 12-month outlook, with consensus target around $22.31, indicating expected upside potential.

Average Target
$22.31
19 analysts
Implied Upside
+0%
vs. current price
Analyst Count
19
covering this stock
Price Range
$18 - $29
Analyst target range
Buy Buy
16 (84%)
Hold Hold
1 (5%)
Sell Sell
2 (11%)

Bulls vs Bears: CVE Investment Factors

Overall, CVE has investment potential but also faces challenges. Here are key factors to weigh before investing.

Bullish Bullish
  • MEG Acquisition Boosts Scale: Deal adds 110,000 bbl/d capacity and unlocks over C$400M in annual synergies by 2028.
  • Analyst Price Target Increases: Multiple firms raised targets, with ATB Cormark boosting from C$29 to C$34.
  • Strong Asset Portfolio: RBC Capital highlighted the company's robust assets as a key strength.
  • Positive Earnings Outlook: Zacks Rank system indicates potential based on earnings estimate revisions.
Bearish Bearish
  • Recent Share Price Decline: Stock slipped 4% over the past month despite a strong yearly gain.
  • Institutional Selling Pressure: TD Asset Management reduced holdings by 27.9% in Q3.
  • Additional Fund Selling: Smead Capital Management decreased its position by 6.6% in Q3.
Reward Banner

CVE Technical Analysis

CVE has delivered exceptional performance with strong double-digit returns across multiple timeframes while maintaining lower volatility than the market.

Over the past three months, CVE has surged 22.2%, significantly outperforming the market by 16.57%, with the 13.3% one-month gain indicating sustained momentum. The low beta of 0.609 suggests this strong performance has been achieved with relatively modest volatility compared to broader market movements.

Currently trading at $22.07, CVE sits near the upper end of its 52-week range ($10.23-$23.39), approximately 5.7% below its yearly high. While not technically overbought, the proximity to the 52-week high combined with a maximum drawdown of -26.32% over the past year warrants monitoring for potential resistance near current levels.

šŸ“Š Beta
0.61
0.61x market volatility
šŸ“‰ Max Drawdown
-26.3%
Largest decline past year
šŸ“ˆ 52-Week Range
$10-$23
Price range past year
šŸ’¹ Annual Return
+61.2%
Cumulative gain past year
Period CVE Return S&P 500
1m +12.6% -1.4%
3m +24.8% +4.1%
6m +48.9% +7.5%
1y +61.2% +15.4%
ytd +27.3% +0.4%

CVE Fundamental Analysis

Revenue & Profitability CVE's Q4 revenue of $10.9B represents a significant sequential decline from Q3's $13.2B, while profitability metrics also weakened substantially. The gross profit margin compressed from 23.2% to 12.1%, and net income declined to $933M with a margin of 8.6%, indicating considerable pressure on earnings. This suggests challenging operating conditions in the quarter compared to the stronger Q3 performance.

Financial Health The company maintains moderate leverage with a debt-to-equity ratio of 0.54 and a conservative debt ratio of 26.8%. Interest coverage remains adequate at 8.2x, though the cash flow to debt ratio of 0.14 indicates limited cash generation relative to outstanding obligations. The current ratio of 1.57 reflects satisfactory short-term liquidity positioning.

Operational Efficiency Operational efficiency metrics show mixed performance, with ROE at 2.95% and asset turnover of 0.17, indicating modest returns on capital deployment. The cash conversion cycle of 5 days demonstrates efficient working capital management, while the fixed asset turnover of 0.23 suggests relatively low utilization of long-term assets. These metrics point to opportunities for improved capital efficiency.

Quarterly Revenue
$10.9B
2025-12
Revenue YoY Growth
-28.4%
YoY Comparison
Gross Margin
12.1%
Latest Quarter
Free Cash Flow
$3.4B
Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

RockFlow Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

Try Now & Get Tesla Stock Reward

Valuation Analysis: Is CVE Overvalued?

Based on the available metrics, CVE appears moderately valued by traditional measures. The trailing PE of 14.06 and forward PE of 11.36 suggest a reasonable current price relative to earnings, with an expectation of earnings growth. However, caution is warranted due to the negative PEG ratio of -0.39, which indicates negative estimated earnings growth and clouds the positive interpretation of the PE ratios. The elevated EV/EBITDA of 22.57 further suggests the company might be richly valued on a cash flow basis.

A peer comparison is not possible as industry average data is unavailable. This absence of context makes it difficult to determine if CVE's valuation multiples of 14.06 (PE TTM) and 1.34 (PB) are attractive relative to its sector. The analysis would be significantly strengthened by benchmarking these figures against industry peers to assess competitive positioning.

PE
14.2x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -19Ɨ-68Ɨ
vs. Industry Avg
N/A
Industry PE ~N/AƗ
EV/EBITDA
22.6x
Enterprise Value Multiple

Investment Risk Disclosure

Volatility Risk: CVE exhibits low equity sensitivity with a Beta of 0.609, suggesting its price moves less dramatically than the broader market. However, its one-year maximum drawdown of -26.32% indicates it has still experienced significant price declines from recent highs. This combination suggests lower relative volatility but a meaningful capacity for temporary capital depreciation.

Other Risks: The absence of significant short interest implies market sentiment is not overtly bearish regarding fundamental weaknesses. Nevertheless, other factors such as general sector exposure to commodity prices or potential liquidity concerns from market capitalization remain as standard equity risks.

FAQs

Is CVE a good stock to buy?

Bullish, but with a caution flag for short-term volatility. The stock offers strong momentum, a reasonable valuation (forward P/E of ~11), and positive analyst sentiment driven by the value-creating MEG acquisition. However, proximity to its 52-week high and recent institutional selling suggest potential for a pullback. This stock is suitable for medium-to-long-term investors who are comfortable with energy sector exposure.

Is CVE stock overvalued or undervalued?

Based on the provided data, CVE stock appears overvalued. While its trailing PE of 14.06 and forward PE of 11.36 seem reasonable on the surface, two key metrics signal overvaluation. First, the negative PEG ratio of -0.39 indicates negative estimated earnings growth, undermining the attractiveness of the PE ratios. Second, the elevated EV/EBITDA of 22.57 suggests the company is richly valued on a cash flow basis, which is particularly concerning given the significant quarter-over-quarter declines in revenue and profitability noted in the fundamental analysis.

What are the main risks of holding CVE?

Based on the provided information, here are the key risks of holding CVE stock, ordered by importance:

1. Commodity Price Volatility: As an energy company, CVE's revenue and profitability are highly susceptible to swings in oil and gas prices, as evidenced by the significant sequential decline in Q4 revenue and profit margins. 2. Execution and Operational Risk: The company's operational efficiency is a concern, with low returns on equity (2.95%) and asset turnover (0.17) indicating potential challenges in profitably deploying capital and managing operations. 3. Financial Flexibility Risk: While leverage is moderate, the low cash flow to debt ratio (0.14) indicates weak cash generation relative to debt obligations, which could constrain financial flexibility, especially if commodity prices remain low. 4. Technical Price Risk: Following a period of strong outperformance, the stock is trading near its 52-week high, increasing its vulnerability to a pullback or consolidation as it encounters technical resistance.

What is the price forecast for CVE in 2026?

Based on the provided analysis, here is a forecast for Cenovus Energy (CVE) through 2026.

My 2026 forecast for CVE anticipates a base case target price of $24-$28 and a bull case of $30-$35, driven by sustained energy commodity prices, successful execution on improving operational efficiency, and strategic debt management. The primary assumption is that WTI crude oil prices stabilize within a $70-$85 per barrel range, allowing CVE to translate its solid financial health into stronger, more consistent profitability. However, this forecast is highly uncertain and heavily dependent on volatile energy markets; a significant downturn in oil prices or failure to achieve operational improvements could result in performance well below these targets.